The newly launched "My Allergies in America" Web site (www.myallergiesinamerica.com) is a comprehensive resource for physicians and individuals with nasal allergies. Launched by Sepracor Inc, the Web portal is based on the 2-part landmark "Allergies in America" survey of adults, adolescents, and children with allergic rhinitis.
"We believe the Web site is a valuable tool that offers important information relative to the experiences and perceptions of nasal allergy sufferers, their caregivers, and health care professionals. We hope that it will become a primary resource for patients and physicians to help gain an understanding of the burden of allergic rhinitis," said Mark H.N. Corrigan, MD, executive vice president of research and development for Sepracor Inc.
The survey, conducted in individuals with nasal allergies 4 years of age and older, assessed the incidence, prevalence, daily life impact, and treatment gaps that currently exist for patients with nasal allergies. The result indicated that adults and children with nasal allergies alike endure bothersome symptoms that adversely impact quality of life. The data also suggested that new treatment options may be necessary as both adults and children seek relief from these symptoms.
Get to know RESPIMAT, the slow-moving mist inhaler from Boehringer Ingelheim Pharmaceuticals, Inc.
Watch the RESPIMAT video and test your knowledge with a short multiple-choice quiz. When you get all the answers right, you’ll receive a certificate naming you a RESPIMAT T.O.P. Performer. Why not check it out today?
Clinical features with downloadable PDFs